Lipoprotein Trafficking in Vascular Cells
暂无分享,去创建一个
[1] G. Evan,et al. Apoptosis of human vascular smooth muscle cells derived from normal vessels and coronary atherosclerotic plaques. , 1995, The Journal of clinical investigation.
[2] R. Fisher,et al. The Third Intracellular Domain of the Platelet-activating Factor Receptor Is a Critical Determinant in Receptor Coupling to Phosphoinositide Phospholipase C-activating G Proteins , 1996, The Journal of Biological Chemistry.
[3] M. Krieger,et al. Molecular flypaper, host defense, and atherosclerosis. Structure, binding properties, and functions of macrophage scavenger receptors. , 1993, The Journal of biological chemistry.
[4] M. Brown,et al. Lipoprotein metabolism in the macrophage: implications for cholesterol deposition in atherosclerosis. , 1983, Annual review of biochemistry.
[5] M. Haberland,et al. Role of lysines in mediating interaction of modified low density lipoproteins with the scavenger receptor of human monocyte macrophages. , 1984, The Journal of biological chemistry.
[6] Helen H. Hobbs,et al. Identification of Scavenger Receptor SR-BI as a High Density Lipoprotein Receptor , 1996, Science.
[7] R. Hamilton,et al. 4-Hydroxynonenal-induced cell death in murine alveolar macrophages. , 1996, Toxicology and applied pharmacology.
[8] D. Jones,et al. Oxidatively modified LDL contains phospholipids with platelet-activating factor-like activity and stimulates the growth of smooth muscle cells. , 1995, The Journal of clinical investigation.
[9] A. Rich,et al. Polynucleotide binding to macrophage scavenger receptors depends on the formation of base-quartet-stabilized four-stranded helices. , 1993, The Journal of biological chemistry.
[10] M. Krieger,et al. Expression cloning of dSR-CI, a class C macrophage-specific scavenger receptor from Drosophila melanogaster. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[11] Wei Sha,et al. Structural Identification by Mass Spectrometry of Oxidized Phospholipids in Minimally Oxidized Low Density Lipoprotein That Induce Monocyte/Endothelial Interactions and Evidence for Their Presence in Vivo * , 1997, The Journal of Biological Chemistry.
[12] D. Steinberg,et al. Cell surface expression of mouse macrosialin and human CD68 and their role as macrophage receptors for oxidized low density lipoprotein. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[13] L. Fong,et al. Inhibition of mouse macrophage degradation of acetyl-low density lipoprotein by interferon-gamma. , 1990, The Journal of biological chemistry.
[14] P. Libby,et al. Macrophage colony-stimulating factor gene expression in vascular cells and in experimental and human atherosclerosis. , 1992, The American journal of pathology.
[15] T. Palkama. Induction of interleukin-1 production by ligands binding to the scavenger receptor in human monocytes and the THP-1 cell line. , 1991, Immunology.
[16] R. E. Pitas,et al. Synergistic Effects of Growth Factors on the Regulation of Smooth Muscle Cell Scavenger Receptor Activity (*) , 1995, The Journal of Biological Chemistry.
[17] S M Schwartz,et al. Angiogenesis in human coronary atherosclerotic plaques. , 1994, The American journal of pathology.
[18] A. Mendez,et al. Protein kinase C as a mediator of high density lipoprotein receptor-dependent efflux of intracellular cholesterol. , 1991, The Journal of biological chemistry.
[19] P. Edwards,et al. The Yin and Yang of oxidation in the development of the fatty streak. A review based on the 1994 George Lyman Duff Memorial Lecture. , 1996, Arteriosclerosis, thrombosis, and vascular biology.
[20] G. Chisolm,et al. Lipoprotein-mediated inhibition of endothelial cell production of platelet-derived growth factor-like protein depends on free radical lipid peroxidation. , 1987, The Journal of biological chemistry.
[21] M. Gimbrone,et al. Lysophosphatidylcholine transcriptionally induces growth factor gene expression in cultured human endothelial cells. , 1994, The Journal of clinical investigation.
[22] A. C. Nicholson,et al. Transforming growth factor-beta up-regulates low density lipoprotein receptor-mediated cholesterol metabolism in vascular smooth muscle cells. , 1992, The Journal of biological chemistry.
[23] D. Hajjar,et al. Signal transduction in atherosclerosis: integration of cytokines and the eicosanoid network , 1992, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[24] G. Chisolm,et al. Roles of multiple oxidized LDL lipids in cellular injury: dominance of 7 beta-hydroperoxycholesterol. , 1996, Journal of lipid research.
[25] M. Hurme,et al. Regulation of endothelial adhesion molecules by ligands binding to the scavenger receptor , 1993, Clinical and experimental immunology.
[26] D. Steinberg,et al. Lysophosphatidylcholine: a chemotactic factor for human monocytes and its potential role in atherogenesis. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[27] A. Akeson,et al. Induction of interleukin 1 beta expression from human peripheral blood monocyte-derived macrophages by 9-hydroxyoctadecadienoic acid. , 1992, The Journal of biological chemistry.
[28] E. Rubin,et al. Human apolipoprotein A-I prevents atherosclerosis associated with apolipoprotein[a] in transgenic mice. , 1994, Journal of lipid research.
[29] T. Kodama,et al. The Scavenger Receptor Serves as a Route for Internalization of Lysophosphatidylcholine in Oxidized Low Density Lipoprotein-induced Macrophage Proliferation* , 1996, The Journal of Biological Chemistry.
[30] T. Mazzone,et al. Platelet-derived growth factor enhances Sp1 binding to the LDL receptor gene. , 1995, Arteriosclerosis, thrombosis, and vascular biology.
[31] W. Mckeehan,et al. Role of lipoproteins in growth of human adult arterial endothelial and smooth muscle cells in low lipoprotein‐deficient serum , 1986, Journal of cellular physiology.
[32] D. Steinberg,et al. Macrophage Oxidation of Low Density Lipoprotein Generates a Modified Form Recognized by the Scavenger Receptor , 1986, Arteriosclerosis.
[33] T. Resink,et al. Induction of growth-related metabolism in human vascular smooth muscle cells by low density lipoprotein. , 1989, The Journal of biological chemistry.
[34] T. McCaffrey,et al. Stimulation of macrophage urokinase expression by polyanions is protein kinase C-dependent and requires protein and RNA synthesis. , 1991, The Journal of biological chemistry.
[35] D. Gospodarowicz,et al. Factors controlling the proliferative rate, final cell density, and life span of bovine vascular smooth muscle cells in culture , 1981, The Journal of cell biology.
[36] J. Berliner,et al. The role of oxidized lipoproteins in atherogenesis. , 1996, Free radical biology & medicine.
[37] M. Bruzelius,et al. Expression of the macrophage scavenger receptor in atheroma. Relationship to immune activation and the T-cell cytokine interferon-gamma. , 1995, Arteriosclerosis, thrombosis, and vascular biology.
[38] A. Lusis,et al. Lipoprotein oxidation and gene expression in the artery wall. New opportunities for pharmacologic intervention in atherosclerosis. , 1993, Biochemical pharmacology.
[39] A. Fogelman,et al. Lipopolysaccharide-induced inhibition of scavenger receptor expression in human monocyte-macrophages is mediated through tumor necrosis factor-alpha. , 1992, Journal of immunology.
[40] J. Freyssinet,et al. Oxysterol-induced apoptosis in human monocytic cell lines. , 1995, Immunobiology.
[41] F. Bühler,et al. Modulation of gene expression by high and low density lipoproteins in human vascular smooth muscle cells. , 1991, Biochemical and biophysical research communications.
[42] R. Assoian,et al. Transforming growth factor-beta 1 inhibits scavenger receptor activity in THP-1 human macrophages. , 1991, The Journal of biological chemistry.
[43] L. Yesner,et al. Regulated expression of CD36 during monocyte-to-macrophage differentiation: potential role of CD36 in foam cell formation. , 1996, Blood.
[44] M. Cybulsky,et al. Lysophosphatidylcholine, a component of atherogenic lipoproteins, induces mononuclear leukocyte adhesion molecules in cultured human and rabbit arterial endothelial cells. , 1992, The Journal of clinical investigation.
[45] R. Alexander,et al. Modified low density lipoprotein and its constituents augment cytokine-activated vascular cell adhesion molecule-1 gene expression in human vascular endothelial cells. , 1995, The Journal of clinical investigation.
[46] D. Morel,et al. 7 beta-hydroperoxycholest-5-en-3 beta-ol, a component of human atherosclerotic lesions, is the primary cytotoxin of oxidized human low density lipoprotein. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[47] P. Edwards,et al. Atherosclerosis: basic mechanisms. Oxidation, inflammation, and genetics. , 1995, Circulation.
[48] F. Parhami,et al. Minimally modified low density lipoprotein-induced inflammatory responses in endothelial cells are mediated by cyclic adenosine monophosphate. , 1993, The Journal of clinical investigation.
[49] H. Lodish,et al. Expression cloning of SR-BI, a CD36-related class B scavenger receptor. , 1994, The Journal of biological chemistry.
[50] V. Natarajan,et al. Oxidized low density lipoprotein-mediated activation of phospholipase D in smooth muscle cells: a possible role in cell proliferation and atherogenesis. , 1995, Journal of lipid research.
[51] M. Haberland,et al. Malondialdehyde-altered protein occurs in atheroma of Watanabe heritable hyperlipidemic rabbits. , 1988, Science.
[52] S. Pizzo,et al. Oxidized Low Density Lipoprotein Suppresses Activation of NFκB in Macrophages via a Pertussis Toxin-sensitive Signaling Mechanism (*) , 1995, The Journal of Biological Chemistry.
[53] U. Steinbrecher,et al. Mechanism of Uptake of Copper-oxidized Low Density Lipoprotein in Macrophages Is Dependent on Its Extent of Oxidation (*) , 1996, The Journal of Biological Chemistry.
[54] D. Steinberg,et al. Role of oxidized low density lipoprotein in atherogenesis. , 1991, The Journal of clinical investigation.
[55] J. Reynolds,et al. Self-association of cholesterol in aqueous solution. , 1973, Proceedings of the National Academy of Sciences of the United States of America.
[56] A. Stopeck,et al. Cytokine regulation of low density lipoprotein receptor gene transcription in HepG2 cells. , 1993, The Journal of biological chemistry.
[57] T. Südhof,et al. The LDL receptor gene: a mosaic of exons shared with different proteins. , 1985, Science.
[58] S. Yokoyama,et al. Independent Regulation of Cholesterol Incorporation into Free Apolipoprotein-mediated Cellular Lipid Efflux in Rat Vascular Smooth Muscle Cells (*) , 1995, The Journal of Biological Chemistry.
[59] R. Silverstein,et al. Oxidized LDL binds to CD36 on human monocyte-derived macrophages and transfected cell lines. Evidence implicating the lipid moiety of the lipoprotein as the binding site. , 1995, Arteriosclerosis, thrombosis, and vascular biology.
[60] N. Simionescu,et al. 4‐Hydroxynonenal induces membrane perturbations and inhibition of basal prostacyclin production in endothelial cells, and migration of monocytes. , 1994, Cell biology international.